You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TCR T Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV Infection After Allogenic HSCT
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 3, 2023

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))

Recruiting
  • Pancreatic Cancer
  • TCR-T Cells Injection（GB3010 Cells Injection）
  • ShangHai, Shanghai, China
    Ruijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023

Solid Tumors Trial (TCR-T cells, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumors
  • TCR-T cells
  • +4 more
  • (no location specified)
Dec 12, 2022

Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • PK Blood Collection
  • +2 more
  • (no location specified)
Nov 1, 2022

Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

Recruiting
  • Cervical Carcinoma
  • TC-E202 cells
  • +3 more
  • Chongqing, Chongqing, China
    Xiaochun Cheng
Oct 20, 2022

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Autologous Mesothelin-specific TCR-T Cells
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 31, 2023

EBV Emia and EBV Positive PTLD After Allogenic HSCT Trial in Sanhe (EBV-TCR-T cells)

Completed
  • EBV Emia and EBV Positive PTLD After Allogenic HSCT
  • EBV-TCR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Mar 6, 2022

Metastatic Colorectal Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 12, 2023

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSH01 injection
  • Nanning, Guang XI, China
    The first affiliated hospital of Guang Xi medical university
Sep 14, 2022

TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSX01-TCRT injection)

Recruiting
  • TCR-T Cells
  • +2 more
  • KSX01-TCRT injection
  • Nanning, Guangxi Zhuang Autonomous Region, China
    The first affiliated hospital of Guang Xi medical university
Mar 31, 2023

CMV Infection or Reactivation After Allogenic HSCT Trial in Sanhe (CMV-TCR-T cells)

Recruiting
  • CMV Infection or Reactivation After Allogenic HSCT
  • CMV-TCR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Jan 29, 2022

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Advanced Solid Tumors Trial in Chongqing (TC-N201 cells, IL-2, Fludarabine)

Recruiting
  • Advanced Solid Tumors
  • TC-N201 cells
  • +4 more
  • Chongqing, China
    TCRCure Biopharma Ltd.
May 25, 2023

CMV Infection After Allogenic HSCT Trial in Beijing (CMV-TCR-T cells)

Recruiting
  • CMV Infection After Allogenic HSCT
  • CMV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 5, 2021

Solid Tumor Trial in Guangzhou (tumor-specific TCR-T cells, Interleukin-2)

Recruiting
  • Solid Tumor
  • Guangzhou, Gaungdong, China
    Sun Yat-sen University Cancer Center
Oct 21, 2021

Hepatocellular Carcinoma Trial in Singapore (mRNA HBV/TCR T-cells)

Recruiting
  • Hepatocellular Carcinoma
  • mRNA HBV/TCR T-cells
  • Singapore, Singapore
    Singapore General Hospital
Jun 27, 2022

Melanoma, Melanoma, Uveal, Head Neck Cancer Trial in Rotterdam (Adoptive therapy with autologous MC2 TCR T cells)

Recruiting
  • Melanoma
  • +2 more
  • Adoptive therapy with autologous MC2 TCR T cells
  • Rotterdam, Netherlands
    Erasmus Medical Center
Jun 1, 2022

Allogeneic Hematopoietic Stem Cell Transplantation, CMV Infection Trial in Beijing (CMV-TCR-T cells)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • CMV Infection
  • CMV-TCR-T cells
  • Beijing, Beijing, China
    Peking University Institute of Hematology,People's hospital Peki
Oct 11, 2021

HLA Typing and Tumor Neoantigen Identification forPhase I/II

Recruiting
  • Ovarian Cancer
  • +5 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Chronic Hepatitis B Trial in Beijing (TCR-T)

    Active, not recruiting
    • Chronic Hepatitis B
    • TCR-T
    • Beijing, China
      The Fifth Medical Center of PLA General Hospital
    Jun 13, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Gastric Cancer, Breast Cancer, Cervical Cancer Trial in New Brunswick (KK-LC-1 TCR-T cells, Aldesleukin 720,000 IU/kg IV every

    Not yet recruiting
    • Gastric Cancer
    • +3 more
    • KK-LC-1 TCR-T cells
    • Aldesleukin 720,000 IU/kg IV every eight hours
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jul 30, 2022

    Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Aldesleukin
    • +12 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 9, 2023